πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8361459

Treatment of stroke and other acute neural degenerative disorders using postpartum-derived

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8357718

Compounds and methods for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8354436

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

4SC DISCOVERY GMBH Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8354419

Benzimidazole analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8350042

Antiviral compounds for the treatment of HCV infection

The Regents of the University of California Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8349888

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8349353

Controlled release cytotoxic agent compositions and methods for the treatment of otic diso

The Regents of the University of California Β· Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338397

Composition and method of treating side effects from antibiotic treatment

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8337866

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamy

The Regents of the University of California Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8334313

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the t

PTC THERAPEUTICS, INC. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8334297

2,4-pyrimidinediamine compounds for treatment of inflammatory disorders

Rigel Pharmaceuticals, Inc. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329924

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329719

Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

Lixte Biotechnology, Inc. Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329636

Carcinoma diagnosis and treatment, based on ODC1 genotype

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8328785

Use of nanoparticles in the photodynamic treatment of tumors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324192

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal trac

The Regents of the University of California Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324275

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatme

Jazz Pharmaceuticals, Inc. Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324178

Method of treatment using alpha-1-adrenergic agonist compounds

The Regents of the University of California Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8323617

Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic aci

ANIKA THERAPEUTICS, INC. Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8322588

Structure containing wound treatment material

Covidien LP Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318817

Controlled release antimicrobial compositions and methods for the treatment of otic disord

The Regents of the University of California Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318156

Anti-cocaine compositions and treatment

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8309525

Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration

The Regents of the University of California Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8303985

Skin treatment compositions containing copper-pigment complexes

Discovery Limited Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted